{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:49:07Z","timestamp":1791226147563,"version":"4.1.0"},"reference-count":247,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Furin, a serine protease enzyme located in the Golgi apparatus of animal cells, plays a crucial role in cleaving precursor proteins into their mature, active forms. It is ubiquitously expressed across various tissues, including the brain, lungs, gastrointestinal tract, liver, pancreas, and reproductive organs. Since its discovery in 1990, furin has been recognized as a significant therapeutic target, leading to the active development of furin inhibitors for potential use in antiviral, antibacterial, anticancer, and other therapeutic applications. This review provides a comprehensive overview of the progress in the development and characterization of furin inhibitors, encompassing peptides, linear and macrocyclic peptidomimetics, and non-peptide compounds, highlighting their potential in the treatment of both infectious and non-infectious diseases.<\/jats:p>","DOI":"10.3390\/ijms25179199","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T05:16:24Z","timestamp":1724649384000},"page":"9199","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Development and Prospects of Furin Inhibitors for Therapeutic Applications"],"prefix":"10.3390","volume":"25","author":[{"given":"Alexandre V.","family":"Ivachtchenko","sequence":"first","affiliation":[{"name":"ChemDiv Inc., San Diego, CA 92130, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Khvat","sequence":"additional","affiliation":[{"name":"ChemDiv Inc., San Diego, CA 92130, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitrii O.","family":"Shkil","sequence":"additional","affiliation":[{"name":"ChemDiv Inc., San Diego, CA 92130, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"21473","DOI":"10.1074\/jbc.R113.481549","article-title":"The Multifaceted Proprotein Convertases: Their Unique, Redundant, Complementary, and Opposite Functions","volume":"288","author":"Seidah","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.1998.tb10727.x","article-title":"Precursor Convertases: An Evolutionary Ancient, Cell-Specific, Combinatorial Mechanism Yielding Diverse Bioactive Peptides and Proteins","volume":"839","author":"Seidah","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/(SICI)1521-1878(200006)22:6<545::AID-BIES7>3.0.CO;2-F","article-title":"A Look at the Caenorhabditis Elegans Kex2\/Subtilisin-like Proprotein Convertase Family","volume":"22","author":"Thacker","year":"2000","journal-title":"BioEssays"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/j.1460-2075.1986.tb04484.x","article-title":"Evolutionary Conserved Close Linkage of the C-Fes\/Fps Proto-Oncogene and Genetic Sequences Encoding a Receptor-like Protein","volume":"5","author":"Roebroek","year":"1986","journal-title":"EMBO J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1126\/science.2683070","article-title":"Intracellular Targeting and Structural Conservation of a Prohormone-Processing Endoprotease","volume":"246","author":"Fuller","year":"1989","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1083\/jcb.111.6.2851","article-title":"Human Fur Gene Encodes a Yeast KEX2-like Endoprotease That Cleaves pro-Beta-NGF in Vivo","volume":"111","author":"Bresnahan","year":"1990","journal-title":"J. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/nar\/18.3.664","article-title":"Structural Homology between the Human Fur Gene Product and the Subtilisin-like Protease Encoded by Yeast KEX2","volume":"18","author":"Keizer","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9378","DOI":"10.1073\/pnas.87.23.9378","article-title":"Expression of a Human Proprotein Processing Enzyme: Correct Cleavage of the von Willebrand Factor Precursor at a Paired Basic Amino Acid Site","volume":"87","author":"Wise","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1016\/S0021-9258(19)39721-2","article-title":"Identification of a Human Insulinoma CDNA Encoding a Novel Mammalian Protein Structurally Related to the Yeast Dibasic Processing Protease Kex2","volume":"265","author":"Smeekens","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrm934","article-title":"Furin at the Cutting Edge: From Protein Traffic to Embryogenesis and Disease","volume":"3","author":"Thomas","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1517\/14728222.12.10.1289","article-title":"Proprotein Convertases as Therapeutic Targets","volume":"12","author":"Seidah","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1074\/jbc.M108740200","article-title":"The Ordered and Compartment-Specfific Autoproteolytic Removal of the Furin Intramolecular Chaperone Is Required for Enzyme Activation","volume":"277","author":"Anderson","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mohan, A.G., Calenic, B., Ghiurau, N.A., Duncea-Borca, R.-M., Constantinescu, A.-E., and Constantinescu, I. (2023). The Golgi Apparatus: A Voyage through Time, Structure, Function and Implication in Neurodegenerative Disorders. Cells, 12.","DOI":"10.3390\/cells12151972"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"28397","DOI":"10.1074\/jbc.270.47.28397","article-title":"Localization of Furin to the Trans-Golgi Network and Recycling from the Cell Surface Involves Ser and Tyr Residues within the Cytoplasmic Domain","volume":"270","author":"Takahashi","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2007-07-100677","article-title":"Furin-Mediated Release of Soluble Hemojuvelin: A New Link between Hypoxia and Iron Homeostasis","volume":"111","author":"Silvestri","year":"2008","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of Therapeutic Targets for SARS-CoV-2 and Discovery of Potential Drugs by Computational Methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhou, B., and Gao, S. (2021). Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.648402"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrd3699","article-title":"The Biology and Therapeutic Targeting of the Proprotein Convertases","volume":"11","author":"Seidah","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e1073","DOI":"10.1002\/cti2.1073","article-title":"Furin-Mediated Protein Processing in Infectious Diseases and Cancer","volume":"8","author":"Braun","year":"2019","journal-title":"Clin. Transl. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The Spike Glycoprotein of the New Coronavirus 2019-NCoV Contains a Furin-like Cleavage Site Absent in CoV of the Same Clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1920","DOI":"10.1002\/cnr2.1920","article-title":"The Possible Role Furin and Furin Inhibitors in Endometrial Adenocarcinoma: A Narrative Review","volume":"7","author":"Alexiou","year":"2024","journal-title":"Cancer Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"BCI.S2049","DOI":"10.4137\/BCI.S2049","article-title":"A 20 Residues Motif Delineates the Furin Cleavage Site and Its Physical Properties May Influence Viral Fusion","volume":"2","author":"Tian","year":"2009","journal-title":"Biochem. Insights"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF00429896","article-title":"Furin Is a Subtilisin-like Proprotein Processing Enzyme in Higher Eukaryotes","volume":"14","author":"Voorberg","year":"1990","journal-title":"Mol. Biol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.1016\/S0021-9258(18)42016-9","article-title":"Human Furin Is a Calcium-Dependent Serine Endoprotease That Recognizes the Sequence Arg-X-X-Arg and Efficiently Cleaves Anthrax Toxin Protective Antigen","volume":"267","author":"Molloy","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/13543776.2014.1000303","article-title":"Therapeutic Uses of Furin and Its Inhibitors: A Patent Review","volume":"25","author":"Couture","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Izaguirre, G. (2019). The Proteolytic Regulation of Virus Cell Entry by Furin and Other Proprotein Convertases. Viruses, 11.","DOI":"10.3390\/v11090837"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1074\/jbc.M703847200","article-title":"Targeting Host Cell Furin Proprotein Convertases as a Therapeutic Strategy against Bacterial Toxins and Viral Pathogens","volume":"282","author":"Shiryaev","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"21992","DOI":"10.1074\/jbc.M111.332643","article-title":"Highly Potent Inhibitors of Proprotein Convertase Furin as Potential Drugs for Treatment of Infectious Diseases","volume":"287","author":"Becker","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s43440-021-00344-x","article-title":"A Perspective on the Applications of Furin Inhibitors for the Treatment of SARS-CoV-2","volume":"74","author":"Devi","year":"2022","journal-title":"Pharmacol. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/jm400633d","article-title":"Optimization of Furin Inhibitors To Protect against the Activation of Influenza Hemagglutinin H5 and Shiga Toxin","volume":"57","author":"Gagnon","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e0012822","DOI":"10.1128\/jvi.00128-22","article-title":"Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity","volume":"96","author":"Essalmani","year":"2022","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"104026","DOI":"10.1016\/j.drudis.2024.104026","article-title":"Targeting Furin, a Cellular Proprotein Convertase, for COVID-19 Prevention and Therapeutics","volume":"29","author":"Jiang","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"de Bruin, A.C.M., Spronken, M.I., Bestebroer, T.M., Fouchier, R.A.M., and Richard, M. (2023). Conserved Expression and Functionality of Furin between Chickens and Ducks as an Activating Protease of Highly Pathogenic Avian Influenza Virus Hemagglutinins. Microbiol. Spectr., 11.","DOI":"10.1128\/spectrum.04602-22"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1099\/vir.0.068585-0","article-title":"Human MicroRNA-24 Modulates Highly Pathogenic Avian-Origin H5N1 Influenza A Virus Infection in A549 Cells by Targeting Secretory Pathway Furin","volume":"96","author":"Loveday","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.antiviral.2015.05.006","article-title":"Peptidomimetic Furin Inhibitor MI-701 in Combination with Oseltamivir and Ribavirin Efficiently Blocks Propagation of Highly Pathogenic Avian Influenza Viruses and Delays High Level Oseltamivir Resistance in MDCK Cells","volume":"120","author":"Lu","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jac\/44.suppl_2.3","article-title":"Epidemiology and Pathogenesis of Influenza","volume":"44","author":"Zambon","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1021\/acsmedchemlett.0c00386","article-title":"Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin","volume":"12","author":"Kwiatkowska","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/360358a0","article-title":"Inhibition of Furin-Mediated Cleavage Activation of HIV-1 Glycoprotein Gpl60","volume":"360","author":"Hallenberger","year":"1992","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-4157(00)00014-9","article-title":"Maturation of HIV Envelope Glycoprotein Precursors by Cellular Endoproteases","volume":"1469","author":"Moulard","year":"2000","journal-title":"Biochim. Et Biophys. Acta (BBA)\u2014Rev. Biomembr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0168-1702(99)00002-7","article-title":"Processing and Routage of HIV Glycoproteins by Furin to the Cell Surface","volume":"60","author":"Moulard","year":"1999","journal-title":"Virus Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0300-9084(94)90149-X","article-title":"Processing of Viral Glycoproteins by the Subtilisin-like Endoprotease Furin and Its Inhibition by Specific Peptidylchloroalkylketones","volume":"76","author":"Garten","year":"1994","journal-title":"Biochimie"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0042-6822(91)90848-6","article-title":"Mutations within the Human Immunodeficiency Virus Type 1 Gp160 Envelope Glycoprotein Alter Its Intracellular Transport and Processing","volume":"184","author":"Willey","year":"1991","journal-title":"Virology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/jvi.66.1.226-234.1992","article-title":"Human Immunodeficiency Virus Type 1 Vpu Protein Regulates the Formation of Intracellular Gp160-CD4 Complexes","volume":"66","author":"Willey","year":"1992","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0042-6822(90)90070-8","article-title":"Characterization of an HIV-1 Point Mutant Blocked in Envelope Glycoprotein Cleavage","volume":"174","author":"Guo","year":"1990","journal-title":"Virology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"21899","DOI":"10.1074\/jbc.M802444200","article-title":"Inhibition of Chikungunya Virus Infection in Cultured Human Muscle Cells by Furin Inhibitors","volume":"283","author":"Ozden","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1128\/JVI.02281-09","article-title":"Initiation of Duck Hepatitis B Virus Infection Requires Cleavage by a Furin-like Protease","volume":"84","author":"Tong","year":"2010","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/liv.12185","article-title":"Therapeutic Potential of Furin Inhibitors for the Chronic Infection of Hepatitis B Virus","volume":"33","author":"Pang","year":"2013","journal-title":"Liver Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1743-422X-11-165","article-title":"Entecavir Combined with Furin Inhibitor Simultaneously Reduces Hepatitis B Virus Replication and e Antigen Secretion","volume":"11","author":"Yang","year":"2014","journal-title":"Virol. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.virol.2010.12.051","article-title":"Hepatitis C Virus-Induced Furin and Thrombospondin-1 Activate TGF-\u03921: Role of TGF-\u03921 in HCV Replication","volume":"412","author":"Presser","year":"2011","journal-title":"Virology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0168-1702(00)00149-0","article-title":"Cleavage of the Respiratory Syncytial Virus Fusion Protein Is Required for Its Surface Expression: Role of Furin","volume":"68","author":"Bolt","year":"2000","journal-title":"Virus Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0042-6822(95)80002-6","article-title":"Proteolytic Processing of Human Cytomegalovirus Glycoprotein B (GpUL55) Is Mediatedby the Human Endoprotease Furin","volume":"206","author":"Vey","year":"1995","journal-title":"Virology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1073\/pnas.95.10.5762","article-title":"Processing of the Ebola Virus Glycoprotein by the Proprotein Convertase Furin","volume":"95","author":"Volchkov","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/bj3530537","article-title":"Implication of the Proprotein Convertases Furin, PC5 and PC7 in the Cleavage of Surface Glycoproteins of Hong Kong, Ebola and Respiratory Syncytial Viruses: A Comparative Analysis with Fluorogenic Peptides","volume":"353","author":"Basak","year":"2001","journal-title":"Biochem. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1073\/pnas.0508815103","article-title":"Cleavage of the Papillomavirus Minor Capsid Protein, L2, at a Furin Consensus Site Is Necessary for Infection","volume":"103","author":"Richards","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2217\/fmb.09.86","article-title":"The Role of Furin in Papillomavirus Infection","volume":"4","author":"Day","year":"2009","journal-title":"Future Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1128\/JVI.00038-16","article-title":"Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins","volume":"90","author":"Bronnimann","year":"2016","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Imran, M., Saleemi, M.K., Chen, Z., Wang, X., Zhou, D., Li, Y., Zhao, Z., Zheng, B., Li, Q., and Cao, S. (2019). Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated PrM Cleavage. Viruses, 11.","DOI":"10.3390\/v11111011"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/iai.63.1.82-87.1995","article-title":"Proteolytic Activation of Bacterial Toxins by Eukaryotic Cells Is Performed by Furin and by Additional Cellular Proteases","volume":"63","author":"Gordon","year":"1995","journal-title":"Infect. Immun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.biocel.2010.02.013","article-title":"Selective and Potent Furin Inhibitors Protect Cells from Anthrax without Significant Toxicity","volume":"42","author":"Remacle","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.1074\/jbc.270.18.10817","article-title":"Furin-Induced Cleavage and Activation of Shiga Toxin","volume":"270","author":"Garred","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1074\/jbc.M310340200","article-title":"Bordetella Dermonecrotic Toxin Undergoes Proteolytic Processing to Be Translocated from a Dynamin-Related Endosome into the Cytoplasm in an Acidification-Independent Manner","volume":"279","author":"Matsuzawa","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/bjc.1997.258","article-title":"Comparative Analysis of Expression of the Proprotein Convertases Furin, PACE4, PC1 and PC2 in Human Lung Tumours","volume":"75","author":"Mbikay","year":"1997","journal-title":"Br. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mc.1057","article-title":"Elevated Furin Expression in Aggressive Human Head and Neck Tumors and Tumor Cell Lines","volume":"31","author":"Bassi","year":"2001","journal-title":"Mol. Carcinog."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/1098-2744(200006)28:2<63::AID-MC1>3.0.CO;2-C","article-title":"The Proprotein Convertases Furin and PACE4 Play a Significant Role in Tumor Progression","volume":"28","author":"Bassi","year":"2000","journal-title":"Mol. Carcinog."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"30686","DOI":"10.1074\/jbc.M101725200","article-title":"Inhibition of Proprotein Convertases Is Associated with Loss of Growth and Tumorigenicity of HT-29 Human Colon Carcinoma Cells","volume":"276","author":"Khatib","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/mc.22131","article-title":"Regulation of HIF-1 Alpha by the Proprotein Convertases Furin and PC7 in Human Squamous Carcinoma Cells","volume":"54","author":"Fu","year":"2015","journal-title":"Mol. Carcinog."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mc.20134","article-title":"Proprotein Convertases: \u201cMaster Switches\u201d in the Regulation of Tumor Growth and Progression","volume":"44","author":"Bassi","year":"2005","journal-title":"Mol. Carcinog."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/s41388-021-02175-9","article-title":"The Proprotein Convertase Furin in Cancer: More than an Oncogene","volume":"41","author":"He","year":"2022","journal-title":"Oncogene"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/mc.22550","article-title":"Targeting Proprotein Convertases in Furin-Rich Lung Cancer Cells Results in Decreased in Vitro and in Vivo Growth","volume":"56","author":"Bassi","year":"2017","journal-title":"Mol. Carcinog."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/ATVBAHA.118.311903","article-title":"FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice","volume":"39","author":"Yakala","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1021\/acsptsci.3c00325","article-title":"Functional Roles of Furin in Cardio-Cerebrovascular Diseases","volume":"7","author":"Wichaiyo","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/03009742.2018.1520294","article-title":"Increased Expression of the Proprotein Convertase Enzyme FURIN in Rheumatoid Arthritis","volume":"48","author":"Valli","year":"2018","journal-title":"Scand. J. Rheumatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e23530","DOI":"10.1002\/jcla.23530","article-title":"Increased FURIN Expression in Rheumatoid Arthritis Patients and Its Anti-Inflammatory Effect","volume":"34","author":"Cao","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1471-4892(02)00148-0","article-title":"Aggrecanase-Mediated Cartilage Degradation","volume":"2","author":"Arner","year":"2002","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2017.04.005","article-title":"Proprotein Convertase Furin\/PCSK3 and Atherosclerosis: New Insights and Potential Therapeutic Targets","volume":"262","author":"Ren","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1161\/CIRCULATIONAHA.104.502617","article-title":"Furin-Like Proprotein Convertases Are Central Regulators of the Membrane Type Matrix Metalloproteinase\u2013Pro-Matrix Metalloproteinase-2 Proteolytic Cascade in Atherosclerosis","volume":"111","author":"Stawowy","year":"2005","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/ijc.30714","article-title":"The Proprotein Convertase Furin in Tumour Progression","volume":"141","author":"Jaaks","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"10326","DOI":"10.1073\/pnas.191199198","article-title":"Furin Inhibition Results in Absent or Decreased Invasiveness and Tumorigenicity of Human Cancer Cells","volume":"98","author":"Bassi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2020.05.001","article-title":"Loss of the Proprotein Convertase Furin in T Cells Represses Mammary Tumorigenesis in Oncogene-Driven Triple Negative Breast Cancer","volume":"484","author":"He","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7812\/TPP\/20.187","article-title":"Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension","volume":"24","author":"Fitzgerald","year":"2020","journal-title":"Perm. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/ATVBAHA.115.305513","article-title":"Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations between Key Biological Processes and Coronary Artery Disease","volume":"35","author":"Ghosh","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cmet.2021.01.016","article-title":"Diabetes, Obesity, Metabolism, and SARS-CoV-2 Infection: The End of the Beginning","volume":"33","author":"Drucker","year":"2021","journal-title":"Cell Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcp.2017.04.027","article-title":"Proprotein Convertase Inhibition: Paralyzing the Cell\u2019s Master Switches","volume":"140","author":"Bassi","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40035-022-00313-1","article-title":"The Emerging Role of Furin in Neurodegenerative and Neuropsychiatric Diseases","volume":"11","author":"Zhang","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"108254","DOI":"10.1016\/j.celrep.2020.108254","article-title":"Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects","volume":"33","author":"Cheng","year":"2020","journal-title":"Cell Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12250-020-00212-7","article-title":"A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-NCoV) Potentially Related to Viral Transmissibility","volume":"35","author":"Wang","year":"2020","journal-title":"Virol. Sin."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Seidah, N.G., Pasquato, A., and Andr\u00e9o, U. (2021). How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?. Viruses, 13.","DOI":"10.20944\/preprints202104.0469.v1"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Villoutreix, B.O., Badiola, I., and Khatib, A.-M. (2022). Furin and COVID-19: Structure, Function and Chemoinformatic Analysis of Representative Active Site Inhibitors. Front. Drug Discov., 2.","DOI":"10.3389\/fddsv.2022.899239"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1021\/acs.jmedchem.1c00518","article-title":"Why All the Fury over Furin?","volume":"65","author":"Osman","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Thomas, G., Couture, F., and Kwiatkowska, A. (2022). The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073435"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4","DOI":"10.12665\/J84.Maples","article-title":"FANG Vaccine: Autologous Tumor Cell Vaccine Genetically Modified to Express GM-CSF and Block Production of Furin","volume":"8","author":"Maples","year":"2010","journal-title":"BioProcess. J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12665\/J81.Maples.P1","article-title":"TAG Xenograft Vaccine: Xenograft-Expanded Autologous Tumor Vaccine Genetically Modified to Express GM-CSF and Block Production of TGFB2 (Part 1)","volume":"8","author":"Kumar","year":"2009","journal-title":"BioProcess. J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/mt.2011.269","article-title":"Phase I Trial of \u201cBi-ShRNAiFurin\/GMCSF DNA\/Autologous Tumor Cell\u201d Vaccine (FANG) in Advanced Cancer","volume":"20","author":"Senzer","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_95","first-page":"8","article-title":"Long Term Follow Up: Phase I Trial of \u201cBi-ShRNA Furin\/GMCSF DNA\/Autologous Tumor Cell\u201d Immunotherapy (FANGTM) in Advanced Cancer","volume":"4","year":"2013","journal-title":"J. Vaccines Vaccin."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000360993","article-title":"Summary of Bi-ShRNAFurin\/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANGTM) in Advanced Cancer of the Liver","volume":"87","author":"Nemunaitis","year":"2014","journal-title":"Oncology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1097\/MPH.0000000000000822","article-title":"Case Report: Immune-Mediated Complete Response in a Patient With Recurrent Advanced Ewing Sarcoma (EWS) After Vigil Immunotherapy","volume":"39","author":"Ghisoli","year":"2017","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/mt.2015.43","article-title":"Pilot Trial of FANG Immunotherapy in Ewing\u2019s Sarcoma","volume":"23","author":"Ghisoli","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/mt.2016.86","article-title":"Three-Year Follow up of GMCSF\/Bi-ShRNAFurin DNA-Transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing\u2019s Sarcoma","volume":"24","author":"Ghisoli","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41417-021-00317-5","article-title":"Proof of Principle Study of Sequential Combination Atezolizumab and Vigil in Relapsed Ovarian Cancer","volume":"29","author":"Rocconi","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/S1525-0016(16)35634-9","article-title":"621 Phase I Study of FANGTM Vaccine in Advanced Ewing\u2019s Sarcoma","volume":"22","author":"Ghisoli","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"24887","DOI":"10.1016\/S0021-9258(19)74548-7","article-title":"Inhibition of HIV-1 Gp160-Dependent Membrane Fusion by a Furin-Directed Alpha 1-Antitrypsin Variant","volume":"268","author":"Anderson","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.95.13.7293","article-title":"\u03b11-Antitrypsin Portland, a Bioengineered Serpin Highly Selective for Furin: Application as an Antipathogenic Agent","volume":"95","author":"Jean","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5","DOI":"10.15407\/ubj91.04.005","article-title":"V 1,3-Oxazol-4-Ylphosphonium Salts as New Non-Peptide Inhibitors of Furin","volume":"91","author":"Osadchuk","year":"2019","journal-title":"Ukr. Biochem. J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.chembiol.2022.02.001","article-title":"A Highly Selective, Cell-Permeable Furin Inhibitor BOS-318 Rescues Key Features of Cystic Fibrosis Airway Disease","volume":"29","author":"Douglas","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s10020-022-00577-3","article-title":"Peptidomimetics in Cancer Targeting","volume":"28","author":"Gomari","year":"2022","journal-title":"Mol. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1021\/acsmedchemlett.3c00008","article-title":"Cyclic Peptidic Furin Inhibitors Developed by Combinatorial Chemistry","volume":"14","author":"Maciejewska","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.chembiol.2022.05.011","article-title":"Clearing the Air: Uniquely Engaging Furin as an Approach to Cystic Fibrosis Therapy","volume":"29","author":"Nayak","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Couture, F., Wang, L., Dufour, F., Chabot-Maheux, K., Ekindi Ndongo, N., Sabbagh, R., and Day, R. (2022). PACE4-AltCT Isoform of Proprotein Convertase PACE4 as Tissue and Plasmatic Biomarker for Prostate Cancer. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-09778-6"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1096\/fj.02-0831rev","article-title":"Curbing Activation: Proprotein Convertases in Homeostasis and Pathology","volume":"17","author":"Taylor","year":"2003","journal-title":"FASEB J."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Mouchlis, V.D., Afantitis, A., Serra, A., Fratello, M., Papadiamantis, A.G., Aidinis, V., Lynch, I., Greco, D., and Melagraki, G. (2021). Advances in De Novo Drug Design: From Conventional to Machine Learning Methods. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041676"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10822-016-9975-3","article-title":"Computer-Aided Drug Design at Boehringer Ingelheim","volume":"31","author":"Muegge","year":"2017","journal-title":"J. Comput.-Aided Mol. Des."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/acs.chemrestox.0c00316","article-title":"Machine Learning in Predictive Toxicology: Recent Applications and Future Directions for Classification Models","volume":"34","author":"Wang","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Shkil, D.O., Muhamedzhanova, A.A., Petrov, P.I., Skorb, E.V., Aliev, T.A., Steshin, I.S., Tumanov, A.V., Kislinskiy, A.S., and Fedorov, M.V. (2024). Expanding Predictive Capacities in Toxicology: Insights from Hackathon-Enhanced Data and Model Aggregation. Molecules, 29.","DOI":"10.3390\/molecules29081826"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"105701","DOI":"10.1016\/j.antiviral.2023.105701","article-title":"Resistance Profiles for the Investigational Neuraminidase Inhibitor AV5080 in Influenza A and B Viruses","volume":"217","author":"Ivashchenko","year":"2023","journal-title":"Antivir. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1007\/s12010-022-03928-2","article-title":"Artificial Neural Network-Based Study Predicts GS-441524 as a Potential Inhibitor of SARS-CoV-2 Activator Protein Furin: A Polypharmacology Approach","volume":"194","author":"Dhanalakshmi","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.ejmech.2008.09.028","article-title":"Modeling the Activity of Furin Inhibitors Using Artificial Neural Network","volume":"44","author":"Worachartcheewan","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1021\/bi00886a039","article-title":"Evidence for an Active-Center Histidine in Trypsin through Use of a Specific Reagent, 1-Chloro-3-Tosylamido-7-Amino-2-Heptanone, the Chloromethyl Ketone Derived from N\u03b1-Tosyl-L-Lysine*","volume":"4","author":"Shaw","year":"1965","journal-title":"Biochemistry"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0003-9861(70)90481-9","article-title":"Further Observations on Substrate-Derived Chloromethyl Ketones That Inactivate Trypsin","volume":"139","author":"Shaw","year":"1970","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Shaw, E. (1974). Progress in Designing Small Inhibitors Which Discriminate among Trypsin-Like Enzymes. Proteinase Inhibitors, Springer.","DOI":"10.1007\/978-3-642-87966-1_58"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/bj1370579","article-title":"Affinity Labelling of Proteinases with Tryptic Specificity by Peptides with C-Terminal Lysine Chloromethyl Ketone","volume":"137","author":"Coggins","year":"1974","journal-title":"Biochem. J."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Kettner, C., and Shaw, E. (1981). [63] Inactivation of Trypsin-like Enzymes with Peptides of Arginine Chloromethyl Ketone. Methods in Enzymology, Academic Press.","DOI":"10.1016\/S0076-6879(81)80065-1"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1248\/cpb.35.3576","article-title":"Synthesis of Peptide Chloromethyl Ketones and Examination of Their Inhibitory Effects on Human Spleen Fibrinolytic Proteinase(SFP) and Human Leukocyte Elastase(LE)","volume":"35","author":"Tsuda","year":"1987","journal-title":"Chem. Pharm. Bull."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1021\/bi00615a027","article-title":"Synthesis of Peptides of Arginine Chloromethyl Ketone. Selective Inactivation of Human Plasma Kallikrein","volume":"17","author":"Kettner","year":"1978","journal-title":"Biochemistry"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0042-6822(89)90103-7","article-title":"Inhibition of Proteolytic Activation of Influenza Virus Hemagglutinin by Specific Peptidyl Chloroalkyl Ketones","volume":"172","author":"Garten","year":"1989","journal-title":"Virology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/j.1460-2075.1992.tb05305.x","article-title":"Influenza Virus Hemagglutinin with Multibasic Cleavage Site Is Activated by Furin, a Subtilisin-like Endoprotease","volume":"11","author":"Vey","year":"1992","journal-title":"EMBO J."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1021\/cr010182v","article-title":"Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases","volume":"102","author":"Powers","year":"2002","journal-title":"Chem. Rev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1042\/bj2930075","article-title":"The Synthesis of Inhibitors for Processing Proteinases and Their Action on the Kex2 Proteinase of Yeast","volume":"293","author":"Angliker","year":"1993","journal-title":"Biochem. J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1021\/acs.jmedchem.5b01516","article-title":"Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases","volume":"59","author":"Kumar","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nsb941","article-title":"The Crystal Structure of the Proprotein Processing Proteinase Furin Explains Its Stringent Specificity","volume":"10","author":"Henrich","year":"2003","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Dahms, S.O., Creemers, J.W.M., Schaub, Y., Bourenkov, G.P., Z\u00f6gg, T., Brandstetter, H., and Than, M.E. (2016). The Structure of a Furin-Antibody Complex Explains Non-Competitive Inhibition by Steric Exclusion of Substrate Conformers. Sci. Rep., 6.","DOI":"10.1038\/srep34303"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"12240","DOI":"10.1016\/S0021-9258(17)32707-2","article-title":"The Convertases Furin and PC1 Can Both Cleave the Human Immunodeficiency Virus (HIV)-1 Envelope Glycoprotein Gp160 into Gp120 (HIV-1 SU) and Gp41 (HIV-I TM)","volume":"269","author":"Decroly","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1021\/jm00020a016","article-title":"Synthesis of Tight Binding Inhibitors and Their Action on the Proprotein-Processing Enzyme Furin","volume":"38","author":"Angliker","year":"1995","journal-title":"J. Med. Chem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"26589","DOI":"10.1074\/jbc.273.41.26589","article-title":"Identification of Inhibitors of Prohormone Convertases 1 and 2 Using a Peptide Combinatorial Library","volume":"273","author":"Apletalina","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723.x","article-title":"Polyarginine Enters Cells More Efficiently than Other Polycationic Homopolymers","volume":"56","author":"Mitchell","year":"2000","journal-title":"J. Pept. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1074\/jbc.M007540200","article-title":"Arginine-Rich Peptides","volume":"276","author":"Futaki","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1074\/jbc.M209548200","article-title":"Cell-Penetrating Peptides","volume":"278","author":"Richard","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ymthe.2004.08.010","article-title":"Cellular Uptake of Arginine-Rich Peptides: Roles for Macropinocytosis and Actin Rearrangement","volume":"10","author":"Nakase","year":"2004","journal-title":"Mol. Ther."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/cbic.200600171","article-title":"Molecular Transporters: Synthesis of Oligoguanidinium Transporters and Their Application to Drug Delivery and Real-Time Imaging","volume":"7","author":"Goun","year":"2006","journal-title":"ChemBioChem"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.addr.2007.10.006","article-title":"Methodological and Cellular Aspects That Govern the Internalization Mechanisms of Arginine-Rich Cell-Penetrating Peptides","volume":"60","author":"Nakase","year":"2008","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/bc700289w","article-title":"Cellular Internalization and Distribution of Arginine-Rich Peptides as a Function of Extracellular Peptide Concentration, Serum, and Plasma Membrane Associated Proteoglycans","volume":"19","author":"Kosuge","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-4598-8-25","article-title":"Hexa-Arginine Enhanced Uptake and Residualization of Selective High Affinity Ligands by Raji Lymphoma Cells","volume":"8","author":"Balhorn","year":"2009","journal-title":"Mol. Cancer"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2010.02.004","article-title":"Acylation of Octaarginine: Implication to the Use of Intracellular Delivery Vectors","volume":"149","author":"Katayama","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Looi, C.Y., Imanishi, M., Takaki, S., Sato, M., Chiba, N., Sasahara, Y., Futaki, S., Tsuchiya, S., and Kumaki, S. (2011). Octa-Arginine Mediated Delivery of Wild-Type Lnk Protein Inhibits TPO-Induced M-MOK Megakaryoblastic Leukemic Cell Growth by Promoting Apoptosis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023640"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcb.23389","article-title":"Amphiphilic Peptides with Arginine and Valine Residues as SiRNA Carriers","volume":"113","author":"Ryu","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Nakase, I., Noguchi, K., Aoki, A., Takatani-Nakase, T., Fujii, I., and Futaki, S. (2017). Arginine-Rich Cell-Penetrating Peptide-Modified Extracellular Vesicles for Active Macropinocytosis Induction and Efficient Intracellular Delivery. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-02014-6"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1021\/acs.bioconjchem.7b00560","article-title":"Unlocking Endosomal Entrapment with Supercharged Arginine-Rich Peptides","volume":"28","author":"Najjar","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4236\/aad.2018.74011","article-title":"Subcutaneous Sustained-Release of Poly-Arginine Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"7","author":"Fonar","year":"2018","journal-title":"Adv. Alzheimer\u2019s Dis."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejpb.2019.02.010","article-title":"Octa-Arginine Boosts the Penetration of Elastin-like Polypeptide Nanoparticles in 3D Cancer Models","volume":"137","author":"Pille","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Hao, M., Zhang, L., and Chen, P. (2022). Membrane Internalization Mechanisms and Design Strategies of Arginine-Rich Cell-Penetrating Peptides. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169038"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"36741","DOI":"10.1074\/jbc.M003848200","article-title":"Polyarginines Are Potent Furin Inhibitors","volume":"275","author":"Cameron","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1128\/IAI.70.12.7136-7139.2002","article-title":"The Furin Inhibitor Hexa-D-Arginine Blocks the Activation of Pseudomonas Aeruginosa Exotoxin A in Vivo","volume":"70","author":"Sarac","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/IAI.72.1.602-605.2004","article-title":"Protection against Anthrax Toxemia by Hexa-D-Arginine in Vitro and in Vivo","volume":"72","author":"Sarac","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jbmr.1738","article-title":"Hexa-D-Arginine Treatment Increases 7B2\u2022PC2 Activity in hyp-Mouse Osteoblasts and Rescues the HYP Phenotype","volume":"28","author":"Yuan","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_155","first-page":"3192","article-title":"Furin Inhibitor D6R Suppresses Epithelial-Mesenchymal Transition in SW1990 and PaTu8988 Cells via the Hippo-YAP Signaling Pathway","volume":"15","author":"Zhou","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"36788","DOI":"10.1074\/jbc.M400484200","article-title":"Inhibition of Furin by Polyarginine-Containing Peptides","volume":"279","author":"Kacprzak","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1021\/jm9012455","article-title":"Potent Inhibitors of Furin and Furin-like Proprotein Convertases Containing Decarboxylated P1 Arginine Mimetics","volume":"53","author":"Becker","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1016\/j.bmcl.2011.06.091","article-title":"New Substrate Analogue Furin Inhibitors Derived from 4-Amidinobenzylamide","volume":"21","author":"Becker","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bmcl.2008.11.019","article-title":"Modification of the N-Terminal Sulfonyl Residue in 3-Amidinophenylalanine-Based Matriptase Inhibitors","volume":"19","author":"Steinmetzer","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1021\/cb500087x","article-title":"X-Ray Structures of Human Furin in Complex with Competitive Inhibitors","volume":"9","author":"Dahms","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/cmdc.201500103","article-title":"Novel Furin Inhibitors with Potent Anti-infectious Activity","volume":"10","author":"Hardes","year":"2015","journal-title":"ChemMedChem"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cmdc.201700108","article-title":"Elongated and Shortened Peptidomimetic Inhibitors of the Proprotein Convertase Furin","volume":"12","author":"Hardes","year":"2017","journal-title":"ChemMedChem"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/cmdc.201700596","article-title":"Optimization of Substrate-Analogue Furin Inhibitors","volume":"12","author":"Ivanova","year":"2017","journal-title":"ChemMedChem"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1080\/14756366.2017.1306521","article-title":"Effects of NS2B-NS3 Protease and Furin Inhibition on West Nile and Dengue Virus Replication","volume":"32","author":"Kouretova","year":"2017","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.celrep.2018.09.018","article-title":"Entry, Replication, Immune Evasion, and Neurotoxicity of Synthetically Engineered Bat-Borne Mumps Virus","volume":"25","author":"Sauder","year":"2018","journal-title":"Cell Rep."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/cmdc.201800807","article-title":"Design, Synthesis, and Characterization of Macrocyclic Inhibitors of the Proprotein Convertase Furin","volume":"14","author":"Ivanova","year":"2019","journal-title":"ChemMedChem"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1021\/acsmedchemlett.0c00651","article-title":"The Basicity Makes the Difference: Improved Canavanine-Derived Inhibitors of the Proprotein Convertase Furin","volume":"12","author":"Heindl","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1021\/jm3011178","article-title":"The Multi-Leu Peptide Inhibitor Discriminates between PACE4 and Furin and Exhibits Antiproliferative Effects on Prostate Cancer Cells","volume":"55","author":"Levesque","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0960-894X(03)00125-2","article-title":"Oxyguanidines: Application to Non-Peptidic Phenyl-Based Thrombin Inhibitors","volume":"13","author":"Tomczuk","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e202000786","DOI":"10.26508\/lsa.202000786","article-title":"TMPRSS2 and Furin Are Both Essential for Proteolytic Activation of SARS-CoV-2 in Human Airway Cells","volume":"3","author":"Bestle","year":"2020","journal-title":"Life Sci. Alliance"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"P\u00e1szti-Gere, E., Szentkir\u00e1lyi, A., Fedor, Z., Nagy, G., Szimr\u00f3k, Z., P\u00e1szti, Z., P\u00e1szti, A., Pilgram, O., Steinmetzer, T., and Bodn\u00e1rov\u00e1, S. (2022). In Vitro Interaction of Potential Antiviral TMPRSS2 Inhibitors with Human Serum Albumin and Cytochrome P 450 Isoenzymes. Biomed. Pharmacother., 146.","DOI":"10.1016\/j.biopha.2021.112513"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e202400057","DOI":"10.1002\/cmdc.202400057","article-title":"Fragment-Based Design, Synthesis, and Characterization of Aminoisoindole-Derived Furin Inhibitors","volume":"19","author":"Lange","year":"2024","journal-title":"ChemMedChem"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e202308251","DOI":"10.1002\/anie.202308251","article-title":"Cyclic Peptides for Drug Development","volume":"63","author":"Ji","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s42004-023-00841-5","article-title":"Self-Cyclisation as a General and Efficient Platform for Peptide and Protein Macrocyclisation","volume":"6","author":"Jia","year":"2023","journal-title":"Commun. Chem."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Costa, L., Sousa, E., and Fernandes, C. (2023). Cyclic Peptides in Pipeline: What Future for These Great Molecules?. Pharmaceuticals, 16.","DOI":"10.3390\/ph16070996"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1039\/D1CB00154J","article-title":"Cyclic Peptide Drugs Approved in the Last Two Decades (2001\u20132021)","volume":"3","author":"Zhang","year":"2021","journal-title":"RSC Chem. Biol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1039\/D1MD00083G","article-title":"Macrocyclization Strategies for Cyclic Peptides and Peptidomimetics","volume":"12","author":"Bechtler","year":"2021","journal-title":"RSC Med. Chem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/1120090-000000000-00000","article-title":"Argatroban","volume":"9","author":"Dhillon","year":"2009","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_179","first-page":"1","article-title":"An Overview of Oxytocin: Chemical Structure, Receptors, Physiological Functions, Measurement Techniques of Oxytocin, and Metabolism","volume":"11","year":"2022","journal-title":"J. Clin. Res. Rep."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0021-9258(18)96750-5","article-title":"The Disulfide Linkages in Kallikrein Inactivator of Bovine Lung","volume":"241","author":"Anderer","year":"1966","journal-title":"J. Biol. Chem."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-291X(65)90749-7","article-title":"The Basic Trypsin Inhibitor of Bovine Pancreas IV. The Linear Sequence of the 58 Amino Acids","volume":"18","author":"Kassell","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"230386","DOI":"10.1155\/2012\/230386","article-title":"Cyclosporine: A Review","volume":"2012","author":"Tedesco","year":"2012","journal-title":"J. Transplant."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/vr.102484","article-title":"Ciclosporin 10 Years on: Indications and Efficacy","volume":"174","author":"Forsythe","year":"2014","journal-title":"Vet. Rec."},{"key":"ref_184","unstructured":"(2024, March 03). Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/Label\/2017\/050790s027lbl.Pdf."},{"key":"ref_185","unstructured":"(2024, March 03). Available online: https:\/\/www.medicalnewstoday.com\/articles\/325563."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1111\/j.1755-5949.2010.00185.x","article-title":"REVIEW: Oxytocin: Crossing the Bridge between Basic Science and Pharmacotherapy","volume":"16","author":"Viero","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1016\/j.bmc.2010.10.014","article-title":"Implication of the Disulfide Bridge in Trypsin Inhibitor SFTI-1 in Its Interaction with Serine Proteinases","volume":"18","author":"Wysocka","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/acs.jmedchem.6b01509","article-title":"Design of Potent and Selective Cathepsin G Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold","volume":"60","author":"Swedberg","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/cbic.201500447","article-title":"Engineering a Constrained Peptidic Scaffold towards Potent and Selective Furin Inhibitors","volume":"16","author":"Fittler","year":"2015","journal-title":"ChemBioChem"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"29721","DOI":"10.1074\/jbc.M705185200","article-title":"An Asparaginyl Endopeptidase Mediates in Vivo Protein Backbone Cyclization","volume":"282","author":"Saska","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.chembiol.2015.04.010","article-title":"Peptide Macrocyclization by a Bifunctional Endoprotease","volume":"22","author":"Nelson","year":"2015","journal-title":"Chem. Biol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1745-7270.2005.00048.x","article-title":"Structural Features and Molecular Evolution of Bowman-Birk Protease Inhibitors and Their Potential Application","volume":"37","author":"Qi","year":"2005","journal-title":"Acta Biochim. Et Biophys. Sin."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Gitlin-Domagalska, A., Maciejewska, A., and D\u0119bowski, D. (2020). Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications. Pharmaceuticals, 13.","DOI":"10.3390\/ph13120421"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/jmbi.1999.2891","article-title":"High-Resolution Structure of a Potent, Cyclic Proteinase Inhibitor from Sunflower Seeds","volume":"290","author":"Luckett","year":"1999","journal-title":"J. Mol. Biol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"13885","DOI":"10.1074\/jbc.M113.460030","article-title":"High-Affinity Cyclic Peptide Matriptase Inhibitors","volume":"288","author":"Quimbar","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1016\/j.bmc.2009.03.045","article-title":"Introduction of Non-Natural Amino Acid Residues into the Substrate-Specific P1 Position of Trypsin Inhibitor SFTI-1 Yields Potent Chymotrypsin and Cathepsin G Inhibitors","volume":"17","author":"Lesner","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/psc.2629","article-title":"Potent Inhibitors of Human Matriptase-1 Based on the Scaffold of Sunflower Trypsin Inhibitor","volume":"20","author":"Fittler","year":"2014","journal-title":"J. Pept. Sci."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acs.jmedchem.8b01139","article-title":"Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma","volume":"62","author":"Swedberg","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1399-3011.2005.00254.x","article-title":"Abbreviated Nomenclature for Cyclic and Branched Homo- and Hetero-detic Peptides","volume":"65","author":"Spengler","year":"2005","journal-title":"J. Pept. Res."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jmedchem.9b00211","article-title":"Amino Acid Scanning at P5\u2032 within the Bowman\u2013Birk Inhibitory Loop Reveals Specificity Trends for Diverse Serine Proteases","volume":"62","author":"Li","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jid.2016.09.017","article-title":"Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum","volume":"137","author":"Furio","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1021\/acs.jmedchem.9b01811","article-title":"Binding Loop Substitutions in the Cyclic Peptide SFTI-1 Generate Potent and Selective Chymase Inhibitors","volume":"63","author":"Li","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1085\/jgp.19.6.991","article-title":"Isolation from Beef Pancreas of Crystalline Trypsinogen, Trypsin, a Trypsin Inhibitor, and an Inhibitor-Trypsin Compound","volume":"19","author":"Kunitz","year":"1936","journal-title":"J. Gen. Physiol."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Ivachtchenko, A.V., Ivashchenko, A.A., Shkil, D.O., and Ivashchenko, I.A. (2023). Aprotinin\u2014Drug against Respiratory Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241311173"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic Drugs","volume":"339","author":"Mannucci","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/bja\/aeh227","article-title":"Perioperative Systemic Haemostatic Agents","volume":"93","author":"Mahdy","year":"2004","journal-title":"Br. J. Anaesth."},{"key":"ref_207","unstructured":"Ivashchenko, A., Svistunov, A., Khorobryh, T., Loginov, V., Karapetian, R., Mishchenko, N., Poyarkov, S., Topr, M., Volgin, M., and Yakubova, E. (2024, March 03). Aprotinin\u2014A New Multi-Target Drug Candidate or \u201cMagic Shotgun\u201d for the Therapy of COVID-19. Available online: https:\/\/covid19-preprints.microbe.ru\/article\/125."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cellsig.2018.08.006","article-title":"Factor XII in Coagulation, Inflammation and Beyond","volume":"51","author":"Didiasova","year":"2018","journal-title":"Cell. Signal."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Sch\u00f6nfelder, K., Breuckmann, K., Elsner, C., Dittmer, U., Fistera, D., Herbstreit, F., Risse, J., Schmidt, K., Sutharsan, S., and Taube, C. (2021). Transmembrane Serine Protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.667231"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nbt0690-565","article-title":"Apropos Aprotinin: A Review","volume":"8","author":"Hewlett","year":"1990","journal-title":"Nat. Biotechnol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_212","first-page":"208","article-title":"Hypertonic Saline and Aprotinin Inhibit Furin and Nasal Protease to Reduce SARS-CoV-2 Specific Furin Site Cleavage Activity","volume":"7","author":"Li","year":"2022","journal-title":"J. Explor. Res. Pharmacol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1778-428X.2004.tb00236.x","article-title":"Antiinflammatory Effects of Aprotinin","volume":"6","author":"Taylor","year":"2004","journal-title":"Transfus. Altern. Transfus. Med."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/jcan.2000.18328","article-title":"High-Dose Aprotinin Modulates the Balance between Proinflammatory and Anti-Inflammatory Responses during Coronary Artery Bypass Graft Surgery","volume":"14","author":"Tassani","year":"2000","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/026765910001500604","article-title":"Inhibition of Neutrophil L-Selectin Shedding: A Potential Anti-Inflammatory Effect of Aprotinin","volume":"15","author":"Asimakopoulos","year":"2000","journal-title":"Perfusion"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1067\/mtc.2000.106323","article-title":"An Anti-Inflammatory Property of Aprotinin Detected at the Level of Leukocyte Extravasation","volume":"120","author":"Asimakopoulos","year":"2000","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5223(19)33735-3","article-title":"Aprotinin Inhibits the Contact, Neutrophil, and Platelet Activation Systems during Simulated Extracorporeal Perfusion","volume":"106","author":"Wachtfogel","year":"1993","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0022-5223(95)70027-7","article-title":"Aprotinin and Methylprednisolone Equally Blunt Cardiopulmonary Bypass\u2013Induced Inflammation in Humans","volume":"110","author":"Hill","year":"1995","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1213\/00000539-199706000-00005","article-title":"Aprotinin but Not Tranexamic Acid Inhibits Cytokine-Induced Inducible Nitric Oxide Synthase Expression","volume":"84","author":"Hill","year":"1997","journal-title":"Anesth. Analg."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/0167-5273(96)02573-9","article-title":"Aprotinin\u00ae Diminishes Inflammatory Processes","volume":"53","author":"Soeparwata","year":"1996","journal-title":"Int. J. Cardiol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2044.1999.00656.x","article-title":"The Effect of Aprotinin on Interleukin-8 Concentration and Leukocyte Adhesion Molecule Expression in an Isolated Cardiopulmonary Bypass System","volume":"54","author":"Gilliland","year":"1999","journal-title":"Anaesthesia"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0003-4975(98)01132-1","article-title":"Pump Prime Only Aprotinin Inhibits Cardiopulmonary Bypass-Induced Neutrophil CD11b up-Regulation","volume":"67","author":"Alonso","year":"1999","journal-title":"Ann. Thorac. Surg."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/cs0940505","article-title":"Aprotinin Reduces Nitric Oxide Production in Vitro and in Vivo in a Dose-Dependent Manner","volume":"94","author":"Bruda","year":"1998","journal-title":"Clin. Sci."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1010-7940(00)00518-2","article-title":"Does Aprotinin Reduce Lung Reperfusion Damage after Cardiopulmonary Bypass?","volume":"18","author":"Rahman","year":"2000","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1128\/JVI.75.19.9297-9301.2001","article-title":"Plasminogen-Binding Activity of Neuraminidase Determines the Pathogenicity of Influenza A Virus","volume":"75","author":"Goto","year":"2001","journal-title":"J. Virol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1099\/0022-1317-65-1-191","article-title":"Suppression of Influenza Virus Replication in Infected Mice by Protease Inhibitors","volume":"65","author":"Zhirnov","year":"1984","journal-title":"J. Gen. Virol."},{"key":"ref_227","unstructured":"(2024, March 03). Available online: https:\/\/epub.ub.uni-muenchen.de\/9483\/1\/9483.pdf."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the Size of the Active Site in Proteases. I. Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_229","doi-asserted-by":"crossref","unstructured":"Fittler, H., Avrutina, O., Glotzbach, B., Empting, M., and Kolmar, H. (2013). Combinatorial Tuning of Peptidic Drug Candidates: High-Affinity Matriptase Inhibitors through Incremental Structure-Guided Optimization. Org. Biomol. Chem., 11.","DOI":"10.1039\/c3ob27469a"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.2174\/138161211798999393","article-title":"Sunflower Trypsin Inhibitor 1 as a Molecular Scaffold for Drug Discovery","volume":"17","author":"Lesner","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Ramos-Molina, B., Lick, A.N., Nasrolahi Shirazi, A., Oh, D., Tiwari, R., El-Sayed, N.S., Parang, K., and Lindberg, I. (2015). Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130417"},{"key":"ref_232","unstructured":"(2024, March 03). Available online: https:\/\/go.drugbank.com\/drugs\/DB06692."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/cmdc.201500532","article-title":"Novel Insights into Structure\u2013Activity Relationships of N-Terminally Modified PACE4 Inhibitors","volume":"11","author":"Kwiatkowska","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0002-9440(10)61140-6","article-title":"Proprotein Convertases in Tumor Progression and Malignancy: Novel Targets in Cancer Therapy","volume":"160","author":"Khatib","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"19707","DOI":"10.1073\/pnas.0606555104","article-title":"Synthetic Small Molecule Furin Inhibitors Derived from 2,5-Dideoxystreptamine","volume":"103","author":"Jiao","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Dahms, S.O., Jiao, G.-S., and Than, M.E. (2017). Structural Studies Revealed Active Site Distortions of Human Furin by a Small Molecule Inhibitor. ACS Chem. Biol., 12.","DOI":"10.1021\/acschembio.6b01110"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bmcl.2010.11.092","article-title":"New Furin Inhibitors Based on Weakly Basic Amidinohydrazones","volume":"21","author":"Sielaff","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ab.2007.01.013","article-title":"Identification of Inhibitors Using a Cell-Based Assay for Monitoring Golgi-Resident Protease Activity","volume":"364","author":"Coppola","year":"2007","journal-title":"Anal. Biochem."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"15729","DOI":"10.1074\/jbc.M901540200","article-title":"Inhibition of Furin\/Proprotein Convertase-Catalyzed Surface and Intracellular Processing by Small Molecules","volume":"284","author":"Komiyama","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1021\/acschembio.1c00411","article-title":"OFF-State-Specific Inhibition of the Proprotein Convertase Furin","volume":"16","author":"Dahms","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"ref_241","unstructured":"(2024, March 03). Available online: https:\/\/patentscope.wipo.int\/search\/en\/detail.Jsf?DocId=WO2019215341."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1021\/acschembio.2c00103","article-title":"Dichlorophenylpyridine-Based Molecules Inhibit Furin through an Induced-Fit Mechanism","volume":"17","author":"Dahms","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"ref_243","first-page":"A3695","article-title":"Starship: Study of Telomeres and Role of Sex Hormones in Pulmonary Fibrosis","volume":"209","author":"Duckworth","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"220256","DOI":"10.1183\/16000617.0256-2022","article-title":"Furin as a Therapeutic Target in Cystic Fibrosis Airways Disease","volume":"32","author":"Douglas","year":"2023","journal-title":"Eur. Respir. Rev."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1016\/j.csbj.2023.09.003","article-title":"W254 in Furin Functions as a Molecular Gate Promoting Anti-Viral Drug Binding: Elucidation of Putative Drug Tunneling and Docking by Non-Equilibrium Molecular Dynamics","volume":"21","author":"Ridgway","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/s41388-020-1238-z","article-title":"The Proprotein Convertase Furin Is a Pro-Oncogenic Driver in KRAS and BRAF Driven Colorectal Cancer","volume":"39","author":"He","year":"2020","journal-title":"Oncogene"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41419-018-1076-x","article-title":"Transgenic Overexpression of Furin Increases Epileptic Susceptibility","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/17\/9199\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:42:53Z","timestamp":1760110973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/17\/9199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":247,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ijms25179199"],"URL":"https:\/\/doi.org\/10.3390\/ijms25179199","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,24]]}}}